Canopy Growth (WEED) reported a slight decline in revenues in its second quarter, but its loss narrowed compared to a year earlier. The giant cannabis company sells a wide range of products including cannabis-infused beverages, edibles, dried flowers, and vapes.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Revenue & Earnings
Net revenue came in at C$131 million for Q2 2022, a decrease of 3% from Q2 2021.
Net earnings for the quarter ended September 30, amounted to a loss of C$16 million (C$0.03 per share), an improvement of C$80 million compared to the prior-year quarter.
Adjusted EBITDA loss in Q2 2022 widened by C$77 million to C$163 million due to lower sales and a decline in operating margins.
Profit Target is Delayed
Canopy Growth has delayed its objective of turning a profit in the second half of fiscal 2022, blaming slower-than-expected sales growth for its CBD-infused products in the U.S. and supply issues in Canada. The company hasn’t specified a new profitability target. (See Analysts’ Top Stocks on TipRanks)
Canopy Growth CFO Mike Lee said, “Achieving profitability remains a top priority. We are focused on increasing market share in Canada, premiumizing our product mix and delivering on our cost savings commitment.”
Wall Street’s Take
On November 2, CIBC analyst John Zamparo reiterated a Hold rating on WEED and set a price target of C$21. This implies 42.5% upside potential.
Overall, WEED scores a Hold rating among Wall Street analysts based on one Buy and eight Holds. The average Canopy Growth price target of C$26.37 implies 79.1% upside potential to current levels
Related News:
Canopy Growth Q2 Earnings Preview: What to Watch
Curaleaf Expands Select Brand, Rolling Stone Partnership
Canopy Growth to Buy Wana Brands; Shares Soar
